Mayer Brown

Described by one practitioner as a firm that emphasizes "experience and client services," Mayer Brown is a multi-service firm that offers particular expertise in the corporate law space, thanks to the contributions of partners Debra Bogo-Ernst and Henninger Bullock. Recently, Bullock represented UCB and its subsidiary Scharz Pharma as national counsel in Reglan litigation. In this matter, the firm has worked to defend their clients against the claims of more than 8,000 plaintiffs, achieving favorable results in the Fifth, Tenth and Eleventh Circuit Courts of Appeal. Furthermore, the matter is at the crux of the conflict relating to the burden of liability between generic and brand-name drug manufacturers. Another product liability practitioner, Daniel Ring, is championed by peers as being "very good in terms of substantive knowledge and strategic judgment, particularly in medical device litigation, and a great team player."

Additionally, the practitioners at Mayer Brown have assisted major life sciences companies in other competition law areas, including Blue Shield of California in an antitrust matter in which the company was alleged to collude with pharmacy managers to boycott the generic form of Lipitor; American Specialty Health Group in a matter relating to the enforcement of non-compete provisions included in collaborative contracts; and several companies in criminal and civil investigations relating to billing and False Claims Act statutes. One of the firm's longstanding clients, Medtronic, regularly solicits the authority of Mayer Brown practitioners, particularly in matters relating to issues of preemption. The firm's work on behalf of Medtronic illustrates a deep expertise in the medical device sector.